226 related articles for article (PubMed ID: 30417460)
21. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
22. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature.
Fassett DR; Pingree J; Kestle JR
J Neurosurg; 2005 Jan; 102(1 Suppl):59-64. PubMed ID: 16206735
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of myxopapillary ependymoma.
Wang H; Zhang S; Rehman SK; Zhang Z; Li W; Makki MS; Zhou X
J Clin Neurosci; 2014 Apr; 21(4):569-73. PubMed ID: 24332590
[TBL] [Abstract][Full Text] [Related]
24. Spinal ependymomas: prognostic factors and treatment results.
Voulgaris S; Alexiou GA; Zigouris A; Fotakopoulos G; Michos E; Katsiafas I; Savvanis G; Pachatouridis D
J Cancer Res Ther; 2013; 9(1):60-3. PubMed ID: 23575076
[TBL] [Abstract][Full Text] [Related]
25. Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina.
Nakamura M; Ishii K; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Chiba K
Spine (Phila Pa 1976); 2009 Oct; 34(21):E756-60. PubMed ID: 19934795
[TBL] [Abstract][Full Text] [Related]
26. Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant.
Chakraborti S; Kini H; Pai KG; Upadhyaya V
J Pediatr Neurosci; 2012 Sep; 7(3):218-20. PubMed ID: 23560014
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of spinal schwannomas and myxopapillary ependymomas: MR imaging and pathologic features.
Ando K; Imagama S; Ito Z; Hirano K; Tauchi R; Muramoto A; Matsui H; Matsumoto T; Sakai Y; Matsuyama Y; Ishiguro N
J Spinal Disord Tech; 2014 Apr; 27(2):105-10. PubMed ID: 22456687
[TBL] [Abstract][Full Text] [Related]
28. Predictors of survival in patients with spinal ependymoma.
Lin Y; Smith ZA; Wong AP; Melkonian S; Harris DA; Lam S
Neurol Res; 2015 Jul; 37(7):650-5. PubMed ID: 25917046
[TBL] [Abstract][Full Text] [Related]
29. TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases.
Deniel A; Marguet F; Beaussire L; Tobenas-Dujardin AC; Peillon C; Gambirasio MA; Veresezan O; Magne N; Di Fiore F; Laquerrière A; Sarafan-Vasseur N; Fontanilles M
World Neurosurg; 2019 Oct; 130():405-409. PubMed ID: 31330336
[TBL] [Abstract][Full Text] [Related]
30. Low-grade ependymoma with late metastasis: autopsy case study and literature review.
Alshaya W; Mehta V; Wilson BA; Chafe S; Aronyk KE; Lu JQ
Childs Nerv Syst; 2015 Sep; 31(9):1565-72. PubMed ID: 25957762
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China.
Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z
BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163
[TBL] [Abstract][Full Text] [Related]
32. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study.
Chen X; Li C; Che X; Chen H; Liu Z
Acta Neurochir (Wien); 2016 Jan; 158(1):101-7. PubMed ID: 26577638
[TBL] [Abstract][Full Text] [Related]
33. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
34. Spinal ependymomas. Part 2: Ependymomas of the filum terminale.
Klekamp J
Neurosurg Focus; 2015 Aug; 39(2):E7. PubMed ID: 26235024
[TBL] [Abstract][Full Text] [Related]
35. Myxopapillary ependymoma with anaplastic features: A case report with review of the literature.
Huynh TR; Lu C; Drazin D; Lekovic G
Surg Neurol Int; 2018; 9():191. PubMed ID: 30294495
[TBL] [Abstract][Full Text] [Related]
36. Ependymomas: MIB-1 proliferation index and survival.
Ritter AM; Hess KR; McLendon RE; Langford LA
J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features, Treatments, and Prognostic Factors of Spinal Myxopapillary Ependymoma.
Fan F; Zhou J; Zheng Y; Liu S; Tang Z; Wang Y
World Neurosurg; 2021 May; 149():e1105-e1111. PubMed ID: 33412325
[TBL] [Abstract][Full Text] [Related]
38. Long term outcomes following surgical resection of myxopapillary ependymomas.
Bagley CA; Wilson S; Kothbauer KF; Bookland MJ; Epstein F; Jallo GI
Neurosurg Rev; 2009 Jul; 32(3):321-34; discussion 334. PubMed ID: 19221818
[TBL] [Abstract][Full Text] [Related]
39. Epithelial differentiation and proliferative potential in spinal ependymomas.
Takeuchi H; Kubota T; Sato K; Llena JF; Hirano A
J Neurooncol; 2002 May; 58(1):13-9. PubMed ID: 12160136
[TBL] [Abstract][Full Text] [Related]
40. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
Kukreja S; Ambekar S; Sin AH; Nanda A
J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
